Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Segment (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 2020

Developing Asian countries such as China and India are lucrative markets for bioinformatics, owing to an increasing number of contract research organizations (CROs), rise in public and private sector investment, and growing industry -academia partnerships.
The report segments the global bioinformatics market by sectors, products and services, application and geography. Knowledge management tools accounted for the largest share of the global bioinformatics market, by product and services in 2014. However, Bioinformatics platforms are expected to grow at the highest CAGR during the forecast period.
Medical biotechnology accounted the largest share of bioinformatics market, by sector. This large share is attributed to increasing use of bioinformatics in drug discovery and development process for the faster development of new safe and effective drugs at a reduced cost.
On the basis of applications, the bioinformatics market is segmented into genomics, chemoinformatics & drug design, proteomics, transcriptomics, metabolomics and molecular phylogenetics. Genomics is expected to be the fastest growing segment in the bioinformatics application market in the next five years.
From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the bioinformatics market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 21
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.4 YEARS CONSIDERED FOR THE STUDY 23
1.5 CURRENCY 23
1.6 LIMITATIONS 23
1.7 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH DATA 24
2.2 MARKET SIZE ESTIMATION 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.3.1 KEY DATA FROM SECONDARY SOURCES 28
2.3.2 KEY DATA FROM PRIMARY SOURCES 29
2.3.2.1 Key industry insights 30
2.3.3 ASSUMPTIONS FOR THE STUDY 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 36
4.1 ATTRACTIVE OPPORTUNITIES IN THE BIOINFORMATICS MARKET 36
4.2 GLOBAL BIOINFORMATICS MARKET, BY PRODUCT 37
4.3 GLOBAL BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES 38
4.4 GLOBAL BIOINFORMATICS MARKET, BY APPLICATION 38
4.5 BIOINFORMATICS MARKET GROWTH OPPORTUNITIES, BY REGION 39
4.6 LIFE CYCLE ANALYSIS, BY REGION 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
5.2.1 DRIVERS 42
5.2.1.1 Growing demand for nucleic acid and protein sequencing 42
5.2.1.2 Increasing funding from government and private organizations 42
5.2.1.3 Rising initiatives by research institutes 42
5.2.1.4 Increasing information technology (IT) support 42
5.2.1.5 Growing applications of bioinformatics in drug discovery and development 42
5.2.1.6 Increasing usage of bioinformatics in clinical diagnostics and personalized medicine 43
5.2.2 RESTRAINTS 44
5.2.2.1 Lack of common data format for integration of data 44
5.2.2.2 Shortage of adequate bioinformatics professionals 44
5.2.2.3 Absence of well-defined standards 44
5.2.2.4 Lack of adequate user-friendly tools 44
5.2.3 OPPORTUNITIES 45
5.2.3.1 Nanopore sequencing technology 45
5.2.3.2 Cloud technology 45
5.2.3.3 Emerging markets (India, China, and Brazil) 46
5.2.4 CHALLENGES 47
5.2.4.1 Management of high volumes of data 47
5.2.5 WINNING IMPERATIVE 47
5.2.5.1 Improved collaborative ties between companies and research institutes 47
6 INDUSTRY TRENDS 48
6.1 VALUE CHAIN ANALYSIS 48
6.2 PORTER’S FIVE FORCES ANALYSIS 49
6.2.1 THREAT FROM NEW ENTRANTS 49
6.2.2 THREAT FROM SUBSTITUTES 49
6.2.3 BARGAINING POWER OF BUYERS 49
6.2.4 BARGAINING POWER OF SUPPLIERS 50
6.2.5 INTENSITY OF COMPETITIVE RIVALRY 50
6.3 STRATEGIC BENCH MARKING 50
6.3.1 NEW PRODUCT LAUNCHES 50
7 BIOINFORMATICS MARKET, BY SECTOR 52
7.1 INTRODUCTION 53
7.2 MEDICAL BIOTECHNOLOGY 55
7.2.1 DRUG DEVELOPMENT 57
7.2.2 CLINICAL DIAGNOSTICS 58
7.2.3 MOLECULAR MEDICINE 59
7.2.3.1 Personalized medicine 59
7.2.3.2 Preventive Medicine 60
7.2.4 GENE THERAPY 60
7.2.5 REPRODUCTIVE BIOTECHNOLOGY 61
7.3 ACADEMICS 62
7.4 ANIMAL BIOTECHNOLOGY 63
7.5 AGRICULTURAL BIOTECHNOLOGY 65
7.5.1 CROP YIELD IMPROVEMENT 66
7.5.2 PEST RESISTANCE 66
7.5.3 IMPROVEMENT OF PLANT RESISTANCE AGAINST ABIOTIC STRESSES 67
7.5.4 NUTRITIONAL QUALITY IMPROVEMENT 68
7.5.5 OTHERS 68
7.6 ENVIRONMENTAL BIOTECHNOLOGY 69
7.6.1 WASTE CLEAN-UP/BIOREMEDIATION 70
7.6.2 ALTERNATIVE ENERGY SOURCES 71
7.6.3 CLIMATE CHANGE STUDIES 71
7.7 FORENSIC BIOTECHNOLOGY 72
7.8 OTHERS 74
8 BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES 76
8.1 INTRODUCTION 77
8.2 KNOWLEDGE MANAGEMENT TOOLS 78
8.2.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 80
8.2.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 81
8.3 BIOINFORMATICS PLATFORMS 82
8.3.1 SEQUENCE ANALYSIS PLATFORMS 83
8.3.2 SEQUENCE ALIGNMENT PLATFORMS 85
8.3.3 SEQUENCE MANIPULATION PLATFORMS 85
8.3.4 STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS 86
8.3.5 OTHER BIOINFORMATICS PLATFORMS 87
8.4 BIOINFORMATICS SERVICES 88
8.4.1 SEQUENCING SERVICES 89
8.4.2 DATABASE AND MANAGEMENT SERVICES 91
8.4.3 DATA ANALYSIS 91
8.4.4 OTHER BIOINFORMATICS SERVICES 92
9 BIOINFORMATICS MARKET, BY APPLICATION 93
9.1 INTRODUCTION 94
9.2 GENOMICS 94
9.3 CHEMOINFORMATICS & DRUG DESIGN 96
9.4 PROTEOMICS 97
9.5 TRANSCRIPTOMICS 99
9.6 METABOLOMICS 100
9.7 MOLECULAR PHYLOGENETICS 101
9.8 OTHER BIOINFORMATICS APPLICATIONS 102
10 BIOINFORMATICS MARKET, BY REGION 103
10.1 INTRODUCTION 104
10.2 NORTH AMERICA 106
10.2.1 U.S. 111
?
10.2.2 CANADA 113
10.3 EUROPE 116
10.4 ASIA-PACIFIC 121
10.4.1 INDIA 126
10.4.2 CHINA 128
10.4.3 REST OF ASIA PACIFIC (ROAP) 129
10.5 REST OF THE WORLD 132
11 COMPETITIVE LANDSCAPE 137
11.1 OVERVIEW 138
11.2 MARKET SHARE ANALYSIS, BIOINFORMATICS MARKET 139
11.3 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY 140
11.4 NEW PRODUCT LAUNCHES 140
11.5 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 142
11.6 ACQUISITIONS 143
11.7 OTHERS DEVELOPMENTS 144
12 COMPANY PROFILES 145
(Overview, Financials, Products & Services, Strategy, & Developments)*
12.1 INTRODUCTION 145
12.2 AFFYMETRIX, INC. 146
12.3 AGILENT TECHNOLOGIES 149
12.4 BIOMAX INFORMATICS AG 152
12.5 GENEVA BIOINFORMATICS (GENEBIO) SA 154
12.6 ID BUSINESS SOLUTIONS LTD. 156
12.7 ILLUMINA, INC. 158
12.8 INTEGROMICS S.L. 163
12.9 NONLINEAR DYNAMICS LTD. (ACQUIRED BY WATERS CORPORATION) 165
12.10 LIFE TECHNOLOGIES 167
12.11 QIAGEN 170
12.12 PERKINELMER, INC. 173
12.13 APPLIED BIOLOGICAL MATERIALS (ABM) 177
12.14 DNANEXUS, INC. 178
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
?
13 APPENDIX 180
13.1 INSIGHTS OF INDUSTRY EXPERTS 180
13.2 DISCUSSION GUIDE 180
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 183
13.4 AVAILABLE CUSTOMIZATIONS 184
13.5 RELATED REPORTS 185